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Purified integrin avb3 was used in solid-phase binding studies with chimeric hepatitis B cores which carry the RGD-
containing loop of VP1 protein of the foot-and-mouth disease virus (FMDV). High levels of specific binding between the
integrin and the particles were detected by enzyme-linked immunosorbent assays. The binding was Mn2/ cation dependent
and could be competed with fibronectin, vitronectin, and the peptide GRGDSPK. Particles in which the RGD motif had been
mutated to RGE failed to bind, indicating that the chimeric cores bound specifically to the ligand binding site of integrin
avb3 . Electron micrographs showed several individual avb3 molecules bound to the surface of each chimeric particle.
Collectively, these data constitute firm evidence that the RGD-containing loop of FMDV is critical for binding to avb3 and
provide support for identification of avb3 as a potential cellular receptor for FMDV. q 1997 Academic Press
INTRODUCTION (Arg-Gly-Asp) tripeptide, such as vitronectin, fibronectin,
osteopontin, fibrinogen, collagen, laminin, neural cell ad-Cell–cell and cell–extracellular matrix adhesive inter-
hesion molecule L1, thrombospondin, and von Wille-actions are essential phenomena in the biology of all
brand factor (Hynes, 1992; Montgomery et al., 1996). Inorganisms and a variety of molecules are responsible
addition, avb3 binds to CD31 (also called platelet endo-for these functions. Integrins are possibly the largest and
thelial cell adhesion molecule or PECAM), a member ofmost complex of the adhesion molecules identified so
the immunoglobulin superfamily which lacks the RGDfar (Giancotti and Mainiero, 1994; Hynes, 1992; Ruoslahti
sequence in any of its six extracellular domains (Buckleyand Pierschbacher, 1987). Adhesive interactions medi-
et al., 1996; Piali et al., 1995).ated by integrins are essential in many biological pro-
The promiscuity of ligand acceptance by integrins hascesses such as cell differentiation, immune recognition,
been exploited by a number of viruses which use themimmune response, and blood coagulation. Integrins are
as receptors at some stage in the infection process andheterodimeric molecules that are formed by the noncova-
this has long been suspected to be the case for foot-lent association of a and b subunits; the molecular
and-mouth disease virus (FMDV). The first indication thatweight of these heterodimers is greater than 200 kDa.
FMDV uses integrins came from comparative sequenceThe integrin avb3 is involved in angiogenesis and in con- data which showed that the motif RGD is highly con-trol of cell migration, and it plays a significant role in
served at a position in the capsid protein, VP1, for whichatherosclerosis, tumor metastasis, and osteoporosis
there was biochemical evidence of involvement in recep-(Hynes, 1992; Giancotti and Mainiero, 1994; Albelda et
tor binding (Geysen et al., 1985). Furthermore, cell attach-al., 1990; Friedlander et al., 1995). Various ligands which
ment by the virus could be competed by synthetic pep-bind to it include adhesive proteins bearing an RGD2
tides bearing the RGD motif (Fox et al., 1989), a feature
indicative of an integrin-ligand interaction. Additionally,1 To whom correspondence and reprint requests should be ad-
structural studies had shown that the RGD triplet wasdressed at Laboratory of Molecular Biophysics, South Parks Road,
located within a highly mobile loop (the bG–bH loopOxford, OX1 3QU, UK. Fax: 44-1865-275182. E-mail: dave@biop.ox.ac.uk.
2 Abbreviations used: RGD, Arg-Gly-Asp; RGE, Arg-Gly-Glu; b-OG, comprising residues 134–159 of the b barrel core of VP1
b-octyl glucoside; BSA, bovine serum albumin; ELISA, enzyme-linked
immunosorbent assay; EM, electron microscope; ICRF, Imperial Cancer
Research Fund; Fn, fibronectin; FMDV, foot-and-mouth disease virus; PBS, phosphate-buffered saline; OPD, o-phenylenediaminedihydro-
chloride; TBS, Tris-buffered saline; Vn, vitronectin.HRP, horseradish peroxidase; ICAM, intercellular adhesion molecule;
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protein) at the surface of FMDV (Fox et al., 1989; Acharya experiments. For integrin purification and solid-phase
binding experiments a mouse monoclonal antibody 23C6et al., 1989); the bG–bH loop had been shown to be in
an open configuration typical of integrin ligands (Logan that recognizes the functional avb3 heterodimer was
used (supplied by ICRF).et al., 1993). The importance of this motif for receptor
binding was confirmed by the demonstration that muta-
Purification of the integrin avb3tion of the sequence to RGE via an infectious clone of
FMDV A12 abolished cell attachment and infectivity (Ma- Integrin avb3 was purified from human placental ex-
son et al., 1994). tracts using antibody-affinity chromatography with
Competition binding experiments using anti-integrin Sepharose-conjugated 23C6, similar to published pro-
monoclonal antibodies suggested that the molecule tocols (Smith and Cheresh, 1988; Pfaff et al., 1994).
used as a receptor by FMDV A12 is avb3 (Berinstein Briefly, a human placenta was homogenized in a com-
et al., 1995). Indeed, recently it has been shown that mercial blender in the presence of 50 mM Tris – Cl, pH
several serotypes (including O1) of FMDV bind to the 7.5, 1 mM MnCl2 , 1 mM MgCl2 , 1 mM CaCl2 , 150 mM
integrin avb3 in vitro (Jackson et al., 1997) via the RGD- NaCl, 1% Triton X-100, 1 mM phenylmethylsulfonyl fluo-
containing loop (the same loop has been used in this ride, and 1 mg/ml each of leupeptin, pepstatin, and
work to generate the chimeric particles). However, it antipain (lysis buffer). The mix was allowed to incubate
is possible that different isolates of FMDV may have at 47 for 1 h and was then spun in a benchtop centrifuge
similar, but not identical, receptor binding specificities to clear the tissue debris and unlysed material. The
since in radiolabeling competition assays heterolo- lysate was then spun in an ultracentrifuge for 1 h at
gous virus does not usually compete as well as homol- 30,000 rpm and the supernatant loaded on a protein
ogous virus for receptor binding (Sekiguchi et al., A – Sepharose column to remove the considerable
1982). The receptor-binding specificity may be modu- amounts of immunoglobulin present in placental mate-
lated by regions of the virus surface other than the rial. Flowthrough was collected and loaded on the
RGD-containing VP1 bG –bH loop since removal of 23C6 antibody column (approximately 30 mg of 23C6
only the C-terminal portion of VP1 has also been shown antibody was coupled to activated Sepharose). The
to compromise cell attachment (Fox et al., 1989; Rieder column was washed with 5 column volumes of lysis
et al., 1994b). Recently, heparan sulfate has been iden- buffer, with and subsequently without Triton X-100.
tified as a primary receptor for the virus (Jackson et al., Acidic buffer (20 mM NaAc, pH 3.1, and 30 mM b-OG)
1996) and it remains unclear to what extent receptor was used to elute the integrin, and 1-ml fractions were
specificity is achieved by each of the two receptors. collected and neutralized simultaneously using 2 M
To examine further the role of the VP1 bG –bH loop Tris – Cl, pH 8.0. These fractions were run on a 9%
of FMDV serotype O1 in determining receptor binding SDS – PAGE gel and visualized by Coomassie blue
and specificity, a DNA sequence coding for this peptide staining. Purified avb3 was judged90% pure by SDS –
was inserted into the e1 loop region of the hepatitis B PAGE gels and was stored at 5 mg/ml in 50 mM Tris –
virus core protein (Chambers et al., 1996). Such fusion Cl, pH 7.5, 1 mM MnCl2 , 0.1 mM MgCl2 , 0.1 mM CaCl2 ,
proteins readily assemble into virus-like particles (FM.e1- 150 mM NaCl, and 30 mM b-OG at 47. A sample of the
HBc) when expressed in bacteria and display an array purified avb3 along with molecular weight markers is
of the introduced sequence on their surface, thus resem- shown in Fig. 1.
bling the natural presentation of the feature on FMDV
(Chambers et al., 1996). These particles can elicit high FM.e1-HBc purification
levels of FMDV-neutralizing antibodies in guinea pigs
Expression and purification of chimeric FM.e1-HBcand compete with virus for binding to cells in culture
(RGD containing), mutant FM.e1-HBc (RGE containing),(Chambers et al., 1996).
and HBc (wild-type cores) was performed as detailedIn this paper we describe features of the binding of
previously (Chambers et al., 1996). Briefly, the native andFM.e1-HBc particles to purified preparations of integrin
chimeric HBc proteins were overexpressed in a bacterialavb3 attached to solid surfaces. We also show electron
expression system and the particles purified by sucrosemicrographs of the integrin molecules bound to the sur-
density gradient centrifugation methods (Chambers et al.,face of the recombinant FM.e1-HBc particles.
1996). Amino acid sequence of the FMDV loop inserted in
chimeric cores is 135-RYSRNAVPNLRGDLQVLAQKV-MATERIALS AND METHODS
ARTLP-160 (Chambers et al., 1996).
Peptides and antibodies
Solid-phase binding assay
An integrin binding peptide GRGDSPK (Pytela et al.,
1987) was synthesized at the Imperial Cancer Research Solid-phase binding assays were performed as fol-
lows: Purified FM.e1-HBc particles and other control pro-Fund (ICRF) facility (London) and used for competition
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mM NaCl, and 30 mM b-OG at room temperature for 1
h. The complex was then spotted onto a carbon-coated
grid, negatively stained with 2% uranyl acetate solution,
and visualized in a JEOL 100 CX (at 100 kV) electron
microscope.
RESULTS
Bacterially produced chimeric FM.e1-HBc particles
bearing the bG–bH loop of VP1 protein bind to
purified human integrin avb3
Human integrin avb3 was affinity purified to homogene-
ity as judged by SDS–PAGE (Fig. 1) by using the hetero-
dimer-specific monoclonal antibody 23C6 (Buckley et al.,
1996). With the use of appropriate monoclonal antibodies
FIG. 1. SDS–PAGE of purified placental integrin avb3 . 20-ml samples it was possible to demonstrate the presence of the av ,of eluted fractions from the antibody column 23C6 were run on a 9%
b3 , and heterodimer avb3 chains, but not of b1 , b5 , orSDS–polyacrylamide gel under nonreducing conditions. Lane 1, broad-
a1 – 6 (data not shown). The binding of purified integrinrange molecular weight markers in daltons (Bio-Rad): 200,000 (top),
116,000, 97,400, 66,000, 45,000, and 31,000; lane 2, the integrin receptor avb3 to the recombinant FM.e1-HBc particles or to other
avb3 showing the two subunits, av at 150,000 and b3 at 90,000 control proteins was assessed by ELISA in which the
daltons. potential ligands were bound to a solid surface. The
FM.e1-HBc particles bound the avb3 with similar dose
response to the natural ligands, fibronectin and vitronec-teins were diluted in 50 mM carbonate–bicarbonate, pH
tin, as shown in Fig. 2A. No significant binding was seen9.6, buffer (Sigma) to a concentration of 5–10 mg/ml and
with either of two control proteins, namely, Fc-ICAM1100 ml was added to a 96-well Nunc-Maxisorp ELISA
and Fc-Muc18 (these are fusion proteins comprising theplate (Gibco, Life Technologies). These microtiter plates
immunoglobulin Fc region fused to the ICAM1 or Muc18were incubated overnight at 47, washed three times with
extracellular domains). In competition assays both fibro-0.25% PBS (wash buffer), and blocked with 200 ml of 2%
nectin and vitronectin reduced the avb3/FM.e1-HBc bind-BSA–PBS for 2 h at room temperature. Wells were again
ing to background levels (Fig. 2B). This suggests that thewashed three times with the wash buffer and 100 ml of
recombinant FM.e1-HBc particles bind to avb3 as thethe purified integrin avb3 (0.1–4 mg/well) was added
natural ligands do.to each well. In competition/inhibition experiments, GRG-
DSPK peptide or other known ligands of integrin avb3
Cation requirements for the binding of avb3were added simultaneously. To assess the effects of
to FM.e1-HBc particlesdivalent cations the integrin and antibody proteins were
diluted in TBS with 1 mM MnCl2 , 0.1 mM MgCl2 , and 0.1
Divalent cations are essential for integrin–ligand inter-mM CaCl2 except for data shown in Fig. 3, for which the
actions and play an important role in regulating the con-integrin was diluted in TBS only. After incubation for 2 h
sequences of such interactions (Pytela et al., 1987). Theat room temperature the wells were washed three times.
effects of cations such as Ca2/, Mg2/, and Mn2/ rangeA 1:5000 dilution of the 23C6 antibody (stock was 1 mg/
from activation of ligand binding to inhibition of ligandml) was then added in 100-ml aliquots to each well and
binding and, possibly, modulation of ligand specificityincubated for 30 min at room temperature followed by
(Hynes, 1992; Gailit and Ruoslahti, 1988; Hu et al., 1995;a 1:1000 dilution of a goat anti-mouse antibody–HRP
Kirchhofer et al., 1990; Smith et al., 1994; Suehiro et al.,conjugate (stock was 1 mg/ml) for the same time period.
1996). To investigate further the binding of FM.e1-HBcWells were finally washed four times, color was devel-
particles to avb3 in the context of divalent cations, ELISAsoped using the OPD substrate (Sigma), and OD was mea-
were performed in the absence of divalent cations or insured at 450 nm.
the presence of 1 mM Ca2/, Mg2/, or Mn2/. As shown
in Fig. 3A, FM.e1-HBc particles bind to avb3 only in theElectron microscopy
presence of 1 mM Mn2/, which is consistent with reports
on the activation of integrins by Mn2/. As expected fromSamples were prepared for negative staining as fol-
lows: 1 mg of FM.e1-HBc particles was incubated with the divalent cation dependence of integrin–ligand inter-
actions, the FM.e1-HBc/avb3 binding was abrogated inapproximately 10 mg of purified avb3 in 50 mM Tris–Cl,
pH 7.5, 1 mM MnCl2 , 0.1 mM MgCl2 , 0.1 mM CaCl2 , 150 the presence of 5 mM EDTA (data not shown).
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FIG. 2. Dose–response and competition experiments. Integrin binding to FM.e1HBc cores was detected as described under Materials and
Methods. (A) Fibronectin, vitronectin, FM.e1-HBc particles, and Fc-ICAM1 and Fc-Muc18 (control proteins) were coated on plastic and increasing
amounts of the integrin avb3 added to each well in the concentration range shown. (B) FM.e1-HBc particles were used to coat microtiter plates
and then incubated with integrin avb3 with (indicated with a / sign) or without (indicated with a 0 sign) 1 mg/well soluble fibronectin (Sigma) or
0.5 mg/well vitronectin (Sigma). Both experiments were done in triplicate and values shown were averaged (where error bars are not shown the
standard deviation was less than 10% of the mean).
FM.e1-HBc/avb3 interaction inhibited by an be300 A˚ (see Fig. 4A), and the diameter of the globular
head of avb3 has previously been determined to be 80RGD-containing peptide
A˚ (A.S., unpublished observations). A distinct decoration
Within the integrin family the b3 integrins show an of the surface of FM.e1-HBc particles with 80-A˚ diame-
apparent lack of specificity toward their ligands outside ter avb3 molecules could be seen in the electron micro-of the RGD motif (Suehiro et al., 1996). Specifically, the graphs (Fig. 4B). Variable numbers of integrin molecules
integrin avb3 has been shown to bind to up to eight were seen on different core particles and no unattached
ligands and recently more have been identified (Hynes, 80-A˚ structures were seen, suggesting that the concen-
1992; Montgomery et al., 1996; Buckley et al., 1996; Piali tration of the avb3 was subsaturating. The complexeset al., 1995). To verify whether the FM.e1-HBc/avb3 inter- were necessarily formed in 30 mM OG since at lower
action was indeed based on the RGD loop of FMDV, and concentrations of the detergent the hydrophobic tails of
to confirm the specificity of this interaction, inhibition integrin avb3 molecules associated to form dimers, tri-studies with a seven-residue RGD peptide (GRGDSPK) mers, and rosettes (A.S., unpublished observations), as
were done. As shown in Fig. 3B the GRGDSPK peptide has been seen with the platelet receptor integrin (Nermut
inhibited binding between FM.e1-HBc and avb3 in a et al, 1988). In light of (a) the biochemical data presented
dose-dependent manner and complete inhibition was here, (b) the fact that purified components (FM.e1-HBc
achieved with 50 mM peptide. Additionally, FM.e1-HBc particles and avb3) were incubated and coated on theparticles in which the RGD sequence was mutated to an carbon-coated grids, and (c) the consistency in molecular
RGE did not bind to the integrin avb3 in solid-phase size of individual components and the FM.e1-HBc/avb3assays (Fig. 3C). These data confirm that FM.e1-HBc/ complexes, it can be concluded that the molecules that
avb3 binding is indeed via the RGD-containing loop of decorate the surface of the FM.e1-HBc particles are spe-
FMDV. cifically bound integrin avb3 .
Visualization of FM.e1-HBc particles complexed with
DISCUSSIONintegrin avb3
To address the structural nature of FM.e1-HBc/avb3 Insertion of the RGD-containing loop from FMDV into
HBc protein confers on the resulting assembled particlesinteraction, potential complexes of FM.e1-HBc/avb3 were
spotted on carbon-coated grids, negatively stained, and (FM.e1-HBc) the ability to bind efficiently to cells and to
a5b1 integrin in vitro (Chambers et al., 1996). Here wevisualized in the EM. The diameter of FM.e1-HBc parti-
cles was estimated from such electron micrographs to show that the chimeric particles can also bind to avb3 ,
AID VY 8833 / 6a53$$$561 11-10-97 13:31:07 viras AP: VY
154 SHARMA ET AL.
FIG. 3. Divalent cation dependence, peptide inhibition, and RGE mutant ELISA. FM.e1-HBc, mutant (RGE) FM.e1-HBc particles, and control proteins
were coated on plates and integrin binding was measured as described under Materials and Methods. (A) Integrin avb3 was diluted in TBS or in
TBS with 1 mM MnCl2 , MgCl2 , or CaCl2 (added to the wells in 1-ml aliquots). Each experiment was done in quadruplicate and average values,
including the background binding of FM.e1-HBc particles and Fc-Muc18 protein, are shown here (where error bars are not shown the standard
deviation was less than 10% of the mean). (B) Peptide competition was performed by adding increasing concentrations (log range) of the peptide
GRGDSPK to microtiter wells in 1-ml aliquots. Fc-ICAM1 and Fc-Muc18 were used as controls. The peptide concentration shown on the x axis is
the final concentration in the well. This experiment was done in triplicate and average values are shown here (where error bars are not shown the
standard deviation was less than 10% of the mean). (C) An RGE mutant of FM.e1-HBc particles was purified and used for solid-phase ELISA. The
wells were coated in quadruplicate with FM.e1-HBc, mutant FM.e1-HBc, and a control protein, Fc-Muc18, and binding of integrin avb3 was performed
as previously. RGD-containing FM.e1-HBc bound significantly to this integrin but the RGE mutant and the control protein Fc-Muc18 did not (where
error bars are not shown the standard deviation was less than 10% of the mean).
an integrin which has been shown to act as a receptor but not Ca2/ or Mg2/ cations. These results suggest
that the chimeric particles mimic natural integrin/ligandfor FMDV (Berinstein et al., 1995). This binding has been
studied in solid-phase ELISA assays as well as by elec- interactions and the system should be valuable for ad-
dressing avidity and amino acid sequence differencestron microscopy. The data indicate that FM.e1-HBc/avb3
binding is divalent cation dependent, can be competed between various pairs of integrin/ligand interactions.
Binding between FM.e1-HBc particles and avb3 iswith fibronectin and vitronectin, and is inhibited by an
RGD-containing peptide. The FM.e1-HBc/avb3 binding is based on the inserted RGD-containing loop of FMDV.
Clearly, this suggests that when the R-G-D sequence ofdependent on the RGD sequence within the bG –bH loop
as mutant particles in which the sequence was changed residues is presented in an appropriate conformation, it
can mimic natural ligands of integrins (one such integrinto RGE did not bind; binding is also dependent on Mn2/
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FIG. 4. Electron microscopy of FM.e1-HBc/avb3 complex. Samples were prepared as described under Materials and Methods. Bar represents
600 A˚. Electron micrograph of negatively stained sample of (A) FM.e1-HBc particles without any added avb3 and (B) with added avb3 . (C) Different
views of various FM.e1-HBc particles decorated with avb3 molecules.
being avb3) and so bind to cell surfaces. Several integrins cle is likely to reflect a favored mode of virus/integrin
interactions over the alternate possibility of virus/singleare capable of binding to RGD-containing proteins (which
are ubiquitous in eukaryotic cells) including aIIbb3 and molecule avb3 binding.
A variety of infectious agents use the RGD sequencemost of b1 integrins (Hynes, 1992). Potentially, several
RGD-binding integrins may therefore be able to bind to to engage cellular receptors for infection, including (a)
echovirus 22 which has an RGD motif in its VP1 proteinsuch mimetics. Therefore, ‘‘loop grafting,’’ in which RGD-
containing loops are inserted into nonadhesive proteins, and is inhibited by RGD-containing peptides (Hyypia et
al., 1992; Stanway et al., 1994), (b) adenovirus which rec-may confer tissue-binding properties on a variety of bio-
logical entities (Maeda et al., 1989; Smith et al., 1995; ognizes avb3 and avb5 integrins by RGD-dependent
mechanisms to aid infection (Defer et al., 1990; Belin andYamada et al., 1995). The extent to which specific inte-
grins can be targeted by altering the context of the RGD Boulanger, 1993; Wickham et al., 1993; Nemerow et al.,
1994), (c) the Lyme disease infectious agent, Borreliamotif remains to be determined, but if this can be
achieved it will bring a new dimension to the potential burgdorferi, which mediates binding to platelet receptor
integrin aIIbb3 by using an RGD motif (Coburn et al., 1993),use of this technique for tissue-specific targeting.
The observation by EM of multiple avb3 molecules and (d) the coxsackievirus A9 which uses its RGD motif
to infect cells via avb3 (Roivainen et al., 1994). In the casebound per particle indicates that there are no major con-
formational changes in the FM.e1-HBc upon the binding of FMDV, the critical role of the RGD loop of VP1 protein
in FMDV infection is well established, as mutation of theof the first avb3 molecule that may inhibit binding of other
avb3 molecules. In the physiological context, FMDV or RGD sequence in this loop abrogates virus attachment
(Rieder et al., 1994a,b). Recently, it has been conclusivelyother RGD-containing infectious agents may bind to avb3
and engage multiple receptors from the same cell or shown that avb3 binding to FMDV occurs via the RGD
sequence (Jackson et al., 1997). However, in some casesdifferent cells to produce an ‘‘in vivo’’ decoration. This
may provide a ‘‘zippering mechanism’’ for internalization the RGD ‘‘password’’ can be bypassed. Thus, FMDV com-
plexed with antibodies can be infectious to cells via anof the virus, and perhaps provide some seclusion from
antibody detection or simply increase the likelihood of antibody-dependent pathway in which the Fc receptors
are used for attachment to cells (Mason et al., 1993;penetration into the cell by increasing the avidity of the
interaction. The multiple receptor engagement per parti- Baxt and Mason, 1995), and coxsackievirus A9 remains
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Albelda, S. M., Mette, S. A., Elder, D. E., Stewart, R., Damjanovich, L.,infectious when shorn of its RGD motif, entering cells via
Herlyn, M., and Buck, C. A. (1990). Integrin distribution in malignantan alternate pathway (Hughes et al., 1995).
melanoma: Association of the beta-3 subunit with tumor progression.
It is possible that the RGD motif on a ligand constitutes Cancer Res. 50, 6757–6764.
a site of ‘‘primary interaction’’ with avb3 , and thereby con- Baxt, B., and Mason, P. W. (1995). Foot-and-mouth disease virus under-
goes restricted replication in macrophage cell cultures following Fcfers general specificity. Additional specificity may be con-
receptor-mediated adsorption. Virology 207, 503–509.ferred by other as yet undetermined contiguous or non-
Belin, M. T., and Boulanger, P. (1993). Involvement of cellular adhesioncontiguous region(s) of the various ligands of avb3 which sequences in the attachment of adenovirus to the HeLa cell surface.
may constitute the site(s) for ‘‘secondary interaction.’’ In J. Gen. Virol. 74, 1485–1497.
this scenario, avb3 can differentiate between its various Berinstein, A., Roivainen, M., Hovi, T., Mason, P. W., and Baxt, B. (1995).
Antibodies to the vitronectin receptor (integrin alpha-v-beta-3) inhibitligands containing the RGD motif subsequent to the pri-
binding and infection of foot-and-mouth disease virus to culturedmary interaction event (a) by making secondary interac-
cells. J. Virol. 69, 2664–2666.tions, (b) by the effects of various divalent cations which
Buckley, C. D., Doyonnas, R., Newton, J. P., Blystone, S. D., Brown, E. J.,
may modulate various conformational states of avb3, (c) Watt, S. M., and Simmons, D. L. (1996). Identification of alpha-v-beta-
by interacting with other moelcules, or (d) by a combina- 3 as a heterotypic ligand for CD31/PECAM-1. J. Cell Sci. 109, 437–
445.tion of these possibilities. If there is no region(s) in RGD-
Chambers, M., Dougan, G., Newman, J., F, B., Crowther, J., Mould,containing ligands which confers additional specificity
A. P., Humphries, M. J., Francis, M. J., Clarke, B., Brown, A. L., andfor secondary interactions then avb3 may be a generic Rowlands, D. (1996). Chimeric hepatitis B virus core particles as
integrin receptor on the cell surface. Such a promiscuous probes for studying peptide–integrin interactions. J. Virol. 70, 4045–
receptor may demand nothing but a well-presented RGD 4052.
Coburn, J., Leong, J. M., and Erban, J. K. (1993). Integrin alpha IIb betaloop for binding. The structural/biochemical basis under-
3 mediates binding of the Lyme disease agent Borrelia burgdorferilying the interaction of avb3 with non-RGD-containing li-
to human platelets. Proc. Natl. Acad. Sci. USA 90, 7059–7063.gands like CD31 will be critical in establishing whether
Defer, C., Belin, M. T., Caillet Boudin, M. L., and Boulanger, P. (1990).
avb3 is such a generic integrin receptor. Future studies Human adenovirus–host cell interactions: Comparative study with
will focus on comparative analyses of adhesive interac- members of subgroups B and C. J. Virol. 64, 3661–3673.
Dransfield, I., Cabanas, C., Craig, A., and Hogg, N. (1992). Divalenttions in the context of avb3-RGD-containing ligands ver-
cation regulation of the function of the leukocyte integrin LFA-1. J.sus avb3-CD31.
Cell Biol. 116, 219–226.The biochemical and electron microscopic analyses
Fox, G., Parry, N. R., Barnett, P. V., McGinn, B., Rowlands, D. J., and
presented pave the way to address the kinetic, thermody- Brown, F. (1989). The cell attachment site on foot-and-mouth disease
namic, and mechanistic aspects of avb3-ligand (natural virus includes the amino acid sequence RGD (arginine-glycine-
aspartic acid). J. Gen. Virol. 70, 625–638.or synthetic) interactions. In addition, comparative stud-
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A.,ies with a range of integrins and viral sequences will
and Cheresh, D. A. (1995). Definition of two angiogenic pathways byhelp delineate rules for virus–integrin interactions. The
distinct alpha-v integrins. Science 270, 1500–1502.
data presented, and recent corroborating data (Be- Gailit, J., and Ruoslahti, E. (1988). Regulation of the fibronectin receptor
rinstein et al., 1995), strongly suggest that the bovine affinity by divalent cations. J. Biol. Chem. 263, 12927–12932.
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